PHARMACEUTICAL COMPOSITION FOR ANTI-INFLAMMATION, OR PROMOTION OF BONE TISSUE FORMATION OR CARTILAGE TISSUE FORMATION, COMPRISING, AS AN ACTIVE INGREDIENT, STAUNTONIA HEXAPHYLLA LEAF-DERIVED EXTRACT OR FRACTIONAL PURIFIED PRODUCT OR NOVEL FLAVONOID COMPOUND AND CAFFEIC ACID COMPOUND SEPARATED THEREFROM

PHARMACEUTICAL COMPOSITION FOR ANTI-INFLAMMATION, OR PROMOTION OF BONE TISSUE FORMATION OR CARTILAGE TISSUE FORMATION, COMPRISING, AS AN ACTIVE INGREDIENT, STAUNTONIA HEXAPHYLLA LEAF-DERIVED EXTRACT OR FRACTIONAL PURIFIED PRODUCT OR NOVEL FLAVONOID COMPOUND AND CAFFEIC ACID COMPOUND SEPARATED THEREFROM

The present invention relates to a production method of a Stauntonia hexaphylla leaf-derived extract or a fractional purified product; a Stauntonia hexaphylla leaf-derived extract or a fractional purified product produced by the production method; and a pharmaceutical composition for anti-inflammati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LEE, Gyu Ok, YOO, Ji-Seok, KIM, Jae Gap, LEE, Dong Gu, KIM, Jae Yong, CHOI, Chulyung, LEE, Yongnam, KANG, Hu Won, KIM, Saerom, PAN, Sang O
Format: Patent
Sprache:eng ; fre ; kor
Schlagworte:
FOODS OR FOODSTUFFS
FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT
THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a production method of a Stauntonia hexaphylla leaf-derived extract or a fractional purified product; a Stauntonia hexaphylla leaf-derived extract or a fractional purified product produced by the production method; and a pharmaceutical composition for anti-inflammation, or promotion of bone tissue formation or cartilage tissue formation, comprising, as an active ingredient, one or more selected from the group consisting of the Stauntonia hexaphylla leaf-derived extract or the fractional purified product, a caffeic acid compound and a novel flavonoid compound separated from the extract or the fractional purified product. La présente invention concerne un procédé de production d'un extrait dérivé des feuilles de Stauntonia hexaphylla ou d'un produit purifié fractionné ; un extrait dérivé des feuilles de Stauntonia hexaphylla ou un produit purifié fractionné produit par ce procédé de production ; et une composition pharmaceutique anti-inflammatoire ou favorisant la formation de tissu osseux ou la formation de tissu cartilagineux, comprenant, en tant que principe actif, un ou plusieurs éléments choisis dans le groupe constitué par l'extrait dérivé des feuilles de Stauntonia hexaphylla ou le produit purifié fractionné, un composé d'acide caféique et un nouveau composé de flavonoïde séparés de l'extrait ou du produit purifié fractionné. 본 발명은, 멀꿀 (Stauntonia hexaphylla) 잎 유래 추출물 또는 분획 정제물의 제조방법, 상기 제조방법으로 제조한 멀꿀 잎 유래 추출물 또는 분획 정제물, 및 상기 멀꿀 잎 유래 추출물 또는 분획 정제물, 또는 상기 추출물 또는 분획 정제물에서 분리된 카페인산 화합물 및 신규 플라보노이드 화합물로 이루어진 군에서 선택된 1 이상을 포함하는 것을 유효성분으로 포함하는, 항염, 또는 골조직 생성 또는 연골조직 생성 촉진용 약학적 조성물에 관한 것이다.